Related Experiment Video
Updated: May 16, 2026
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma
Colin I Clement1, George Kampougeris, Faisal Ahmed
1Glaucoma Unit, Western Eye Hospital, London, UK. colinc1@med.usyd.edu.au
Clinical & Experimental Ophthalmology
|December 13, 2012
Summary
Combined phacoemulsification and endoscopic cyclophotocoagulation effectively treats cataract and glaucoma, significantly reducing intraocular pressure and improving vision. This combined surgical approach offers a safe and beneficial option for patients with both conditions.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Glaucoma Management
Background:
- Cataract and glaucoma frequently coexist, necessitating combined surgical strategies.
- Current management often involves separate procedures, increasing patient burden and potential complications.
Purpose of the Study:
- To evaluate the safety and efficacy of combined phacoemulsification and endoscopic cyclophotocoagulation.
- To assess the impact on intraocular pressure, visual acuity, and medication use.
- To identify any complications associated with the combined procedure.
Main Methods:
- A retrospective, uncontrolled case series involving 63 eyes from 59 patients with coexisting cataract and glaucoma.
- Patients underwent a single procedure combining phacoemulsification with 270-360 degrees of endoscopic cyclophotocoagulation.
- Outcomes measured included intraocular pressure, medication use, visual acuity, and complications.
Main Results:
- At 12 months post-surgery, mean intraocular pressure decreased significantly (P < 0.01) and the number of medications reduced (P < 0.01).
- Mean logMAR visual acuity improved significantly (P < 0.01).
- A success rate of 55.5% was achieved, defined by a >20% intraocular pressure reduction within the 6-21 mmHg range.
Conclusions:
- Combined phacoemulsification and endoscopic cyclophotocoagulation is a safe and effective surgical treatment for patients with both cataract and glaucoma.
- Greater reductions in intraocular pressure were observed in older patients and those with higher baseline intraocular pressure.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...